M&T Bank enters the final week of September carrying a 5% weekly loss — but the more interesting tension is that short sellers have been reducing exposure even as the stock falls, and the Street's most prominent recent voice just moved firmly bullish.
The price decline is real but not idiosyncratic. MTB dropped 5.1% on the week to $223.42, down 7% over the past month. Peers moved in lockstep: RF fell 6.0% on the week, CFG dropped 6.8%, and ZION shed 6.4%. PNC lost 5.3%. This is a broad regional bank selloff, not a stock-specific story — which makes the divergence between price action and short positioning all the more notable.
Short sellers are not pressing the move. Short interest slipped 2.3% on the week to 3.2% of the free float — a level that isn't extreme by any measure, and one that has been drifting lower since peaking above 6 million shares in early September. The borrow market reflects that complacency: cost to borrow is barely 0.43%, and availability is extraordinarily loose at nearly 3,000% of short interest, meaning there are roughly 30 shares available in the lending pool for every one already borrowed. That's well above the 52-week minimum of 600%. The ORTEX short score has eased from 39.4 a week ago to 38.4 — low enough to rank in just the 33rd percentile for short pressure across the universe. The options market agrees: the put/call ratio of 0.45 is actually running a touch below its 20-day average, with a z-score of -1.05, suggesting call demand is if anything slightly elevated relative to recent norms. Positioning looks relaxed rather than defensive, even into the dip.
The Street narrative is split between cautious acknowledgment of the selloff and a notably fresh bullish call. Morgan Stanley's Manan Gosalia upgraded MTB to Overweight on September 8th, lifting his target from $253 to $304 — a move that stands out for its conviction given the subsequent price weakness. The consensus mean target of $258.86 implies roughly 16% upside from current levels, and most of the post-Q2 activity was upgrades or target increases: Cantor Fitzgerald, JP Morgan, RBC Capital, and Truist all lifted targets in late July after Q2 results. The one exception this week is Truist, which cut its target to $250 from $268 this morning while maintaining a Hold — an acknowledgment that the stock has given back much of its post-earnings rally. Wells Fargo's Mike Mayo remains the outlier bear, holding an Underweight with a $224 target that is almost exactly where the stock is now trading. On valuation, MTB trades at 10.9x trailing earnings and 1.18x book — undemanding multiples for a bank posting 3.71% net interest margin. The dividend factor score ranks in the 93rd percentile, and the stock has a strong track record of beating estimates (EPS surprise ranks 80th percentile), though forward earnings growth estimates remain subdued.
The CEO's recent filings add one layer of context — though not a conventional signal. Chairman and CEO René Jones exercised options and sold shares on September 14th, generating a net sale of roughly $4.6 million, all under a pre-arranged 10b5-1 plan. Planned sales of this type carry far less informational weight than discretionary transactions. Across all insiders, the 90-day net position is a disposal of about $6 million in value — driven almost entirely by the CEO's structured plan rather than any cluster of discretionary selling. The institutional register is stable: BlackRock holds 8.9% and Fidelity (FMR LLC) 6.2%, with no activist 13D on the register.
Q3 results are due October 16th. The last print in July produced a clean +5% one-day move and held most of those gains through the following week. Whether the current selloff represents a reset of expectations ahead of that report — or simply the sector repricing rate expectations — is the question the next few weeks will answer.
See the live data behind this article on ORTEX.
Open MTB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
